Affimed Announces New Innate Cell Engager AFM28 Targeting - GlobeNewswire

Retrieved on: 2021-11-04 13:08:34

Tags for this article:

Medical specialties

Branches of biology

Organ systems

Immune system

Lymphocytes

Interleukin-3 receptor

Acute myeloid leukemia

Tumors of the hematopoietic and lymphoid tissues

Cancer immunotherapy

Myelodysplastic syndrome

Click the tags to see associated articles and topics

Affimed Announces New Innate Cell Engager AFM28 Targeting - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2021/11/04/2327659/0/en/Affimed-Announces-New-Innate-Cell-Engager-AFM28-Targeting-CD123-to-Treat-Acute-Myeloid-Leukemia.html

Excerpt

... to monoclonal antibodies which may lead to enhanced ADCC in patients ... to CD123 and to CD16A is initiating antibody-dependent cell-mediated ...

Article found on: www.globenewswire.com

View Original Article